CoChat

Candida albicans biofilm–induced vesicles confer drug resistance through matrix biogenesis

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Cells from all kingdoms of life produce extracellular vesicles (EVs). Their cargo is protected from the environment by the surrounding lipid bilayer. EVs from many organisms have been shown to function in cell-cell communication, relaying signals that impact metazoan development, microbial quorum sensing, and pathogenic host-microbe interactions. Here, we have investigated the production and functional activities of EVs in a surface-associated microbial community or biofilm of the fungal pathogen Candida albicans. Crowded communities like biofilms are a context in which EVs are likely to function. Biofilms are noteworthy because they are encased in an extracellular polymeric matrix and because biofilm cells exhibit extreme tolerance to antimicrobial compounds. We found that biofilm EVs are distinct from those produced by free-living planktonic cells and display strong parallels in composition to biofilm matrix material. The functions of biofilm EVs were delineated with a panel of mutants defective in orthologs of endosomal sorting complexes required for transport (ESCRT) subunits, which are required for normal EV production in diverse eukaryotes. Most ESCRT-defective mutations caused reduced biofilm EV production, reduced matrix polysaccharide levels, and greatly increased sensitivity to the antifungal drug fluconazole. Matrix accumulation and drug hypersensitivity of ESCRT mutants were reversed by addition of wild-type (WT) biofilm EVs. Vesicle complementation showed that biofilm EV function derives from specific cargo proteins. Our studies indicate that C. albicans biofilm EVs have a pivotal role in matrix production and biofilm drug resistance. Biofilm matrix synthesis is a community enterprise; prior studies of mixed cell biofilms have demonstrated extracellular complementation. Therefore, EVs function not only in cell-cell communication but also in the sharing of microbial community resources.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.2006872

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 C. albicans biofilms secrete unique EVs. (a) A SEM of EV-like structures on the surface of C. albicans growing in a biofilm. Scale bar indicates 0.6 μm. (b) A SEM of EV-like structures within deposits of the extracellular matrix in biofilms. Scale bar indicates 0.5 μm. (c) A cryoTEM of Candida biofilm-derived EVs are surrounded by a 7-nm-thick lipid bilayer. Scale bar indicates 100 nm. (d) Quantitative analysis of EVs in C. albicans biofilms measured at various culture growth time points using imaging flow cytometry. Biofilm cell number was quantified by dry weight. The measurements were done in triplicate. (e) Size distribution of C. albicans planktonic EVs evaluated by dynamic light scattering. (f) Size distribution of C. albicans biofilm EVs evaluated by dynamic light scattering. Underlying data can be found in S1 Data. EV, extracellular vesicle; SEM, scanning electron micrograph.
Fig 1 C. albicans biofilms secrete unique EVs. (a) A SEM of EV-like structures on the surface of C. albicans growing in a biofilm. Scale bar indicates 0.6 μm. (b) A SEM of EV-like structures within deposits of the extracellular matrix in biofilms. Scale bar indicates 0.5 μm. (c) A cryoTEM of Candida biofilm-derived EVs are surrounded by a 7-nm-thick lipid bilayer. Scale bar indicates 100 nm. (d) Quantitative analysis of EVs in C. albicans biofilms measured at various culture growth time points using imaging flow cytometry. Biofilm cell number was quantified by dry weight. The measurements were done in triplicate. (e) Size distribution of C. albicans planktonic EVs evaluated by dynamic light scattering. (f) Size distribution of C. albicans biofilm EVs evaluated by dynamic light scattering. Underlying data can be found in S1 Data. EV, extracellular vesicle; SEM, scanning electron micrograph.CC BY · PubMed Central
Fig 2 Unique C. albicans biofilm EV protein, lipid, and carbohydrate cargo delivers biofilm extracellular matrix components. Biofilm EVs proteomes are shown in orange versus planktonic EVs shown in blue (a, b, c), whereas ECM is shown in green (d, e, f). Smallest regions (a, b, d, e) represent identified proteins and are arranged inside higher level regions according to their KEGG functional category and pathway assignment by using a Voronoi treemap layout. (a, b) Log2 biofilm EVs/planktonic EVs ratios of proteins relative abundances were mapped to a color ramp starting with orange (more protein in biofilm EVs), passing grey (similar protein proportions in biofilm EVs as well as planktonic EVs), and reaching blue (more protein in planktonic cells). (c) The number of exclusive (blue and orange) and common (white) biofilm EVs and planktonic EVs proteins are illustrated by using a Venn diagram. (d, e, f) Accordingly, the proteome comparisons of biofilm EVs (orange) and ECM (green) are shown. (I) Lipidomics profiles in biofilm EVs and the ECM. The treemaps reflect relative amounts of individual lipid species present in EVs or ECM. The coloration of individual clusters based on their classification showing phospholipids in orange, neutral lipids in red, and sphingolipids in blue. Quantitative differences of biofilm EVs lipids and extracellular matrix lipids are given by using z-scores. Blue illustrates lipids with higher concentrations in biofilm EVs, whereas orange reflects lipids more abundant in ECM. ECM, extracellular matrix; EV, extracellular vesicle; KEGG, Kyoto Encyclopedia of Genes and Genomes.
Fig 2 Unique C. albicans biofilm EV protein, lipid, and carbohydrate cargo delivers biofilm extracellular matrix components. Biofilm EVs proteomes are shown in orange versus planktonic EVs shown in blue (a, b, c), whereas ECM is shown in green (d, e, f). Smallest regions (a, b, d, e) represent identified proteins and are arranged inside higher level regions according to their KEGG functional category and pathway assignment by using a Voronoi treemap layout. (a, b) Log2 biofilm EVs/planktonic EVs ratios of proteins relative abundances were mapped to a color ramp starting with orange (more protein in biofilm EVs), passing grey (similar protein proportions in biofilm EVs as well as planktonic EVs), and reaching blue (more protein in planktonic cells). (c) The number of exclusive (blue and orange) and common (white) biofilm EVs and planktonic EVs proteins are illustrated by using a Venn diagram. (d, e, f) Accordingly, the proteome comparisons of biofilm EVs (orange) and ECM (green) are shown. (I) Lipidomics profiles in biofilm EVs and the ECM. The treemaps reflect relative amounts of individual lipid species present in EVs or ECM. The coloration of individual clusters based on their classification showing phospholipids in orange, neutral lipids in red, and sphingolipids in blue. Quantitative differences of biofilm EVs lipids and extracellular matrix lipids are given by using z-scores. Blue illustrates lipids with higher concentrations in biofilm EVs, whereas orange reflects lipids more abundant in ECM. ECM, extracellular matrix; EV, extracellular vesicle; KEGG, Kyoto Encyclopedia of Genes and Genomes.CC BY · PubMed Central
Fig 3 ESCRT driven biofilm EVs are responsible for drug resistance due to delivery of macromolecules to the C. albicans extracellular matrix. (a) A diagram of the ESCRT machinery involved in sorting cargo via EVs. (b) Quantitative analysis of biofilm EVs in the C. albicans WT strain and the ESCRT null mutants assessed by the imaging flow cytometry system. The experiment and assays were done in triplicate and data presented as particles per ml. Bars indicate standard deviation of the median. (c) The percent of reduction in biofilm formation following 48-h treatment with fluconazole (1 mg/ml) compared with untreated biofilms, as quantified using the 96-well XTT assay. The null deletions and corresponding complemented strains are shown for mutants with fluconazole susceptibility phenotype. The experiments and assays were performed in triplicate. Asterisks indicate values significantly different from the reference strain based on one-way ANOVA with the posthoc Tukey HSD test. Bars indicate standard deviation of the median. (d) Quantification of in vivo biofilms using a rat central venous catheter model. Individual fluconazole-susceptible ESCRT null mutants were treated either with fluconazole 250 μg/ml or 0.9 M NaCl followed by the CFU analysis. Three animal and culture replicates per condition. (e) Sequestration of 3H-labelled fluconazole by intact biofilms grown from the reference and ESCRT mutant strains. Biofilms were exposed to the radiolabeled drug, washed, and harvested. Scintillation counting was performed in triplicate to determine the fluconazole content in the intact biofilms and the isolated matrix. (f) The percent reduction of mannan and glucan concentration in biofilm matrices of fluconazole-susceptible ESCRT null mutants measured by gas chromatography. Three biological and assay replicates per data point. (g) Impact of ESCRT null mutants on biofilm architecture and extracellular matrix based upon SEM imaging of mature (24 h) in vitro biofilms. Underlying data can be found in S1 Data. CFU, colony-forming unit; ESCRT, endosomal sorting complexes required for transport; EV, extracellular vesicle; H, hydrogen; HSD, honestly significant difference; NaCl, sodium chloride; SEM, scanning electron micrograph; WT, wild-type.
Fig 3 ESCRT driven biofilm EVs are responsible for drug resistance due to delivery of macromolecules to the C. albicans extracellular matrix. (a) A diagram of the ESCRT machinery involved in sorting cargo via EVs. (b) Quantitative analysis of biofilm EVs in the C. albicans WT strain and the ESCRT null mutants assessed by the imaging flow cytometry system. The experiment and assays were done in triplicate and data presented as particles per ml. Bars indicate standard deviation of the median. (c) The percent of reduction in biofilm formation following 48-h treatment with fluconazole (1 mg/ml) compared with untreated biofilms, as quantified using the 96-well XTT assay. The null deletions and corresponding complemented strains are shown for mutants with fluconazole susceptibility phenotype. The experiments and assays were performed in triplicate. Asterisks indicate values significantly different from the reference strain based on one-way ANOVA with the posthoc Tukey HSD test. Bars indicate standard deviation of the median. (d) Quantification of in vivo biofilms using a rat central venous catheter model. Individual fluconazole-susceptible ESCRT null mutants were treated either with fluconazole 250 μg/ml or 0.9 M NaCl followed by the CFU analysis. Three animal and culture replicates per condition. (e) Sequestration of 3H-labelled fluconazole by intact biofilms grown from the reference and ESCRT mutant strains. Biofilms were exposed to the radiolabeled drug, washed, and harvested. Scintillation counting was performed in triplicate to determine the fluconazole content in the intact biofilms and the isolated matrix. (f) The percent reduction of mannan and glucan concentration in biofilm matrices of fluconazole-susceptible ESCRT null mutants measured by gas chromatography. Three biological and assay replicates per data point. (g) Impact of ESCRT null mutants on biofilm architecture and extracellular matrix based upon SEM imaging of mature (24 h) in vitro biofilms. Underlying data can be found in S1 Data. CFU, colony-forming unit; ESCRT, endosomal sorting complexes required for transport; EV, extracellular vesicle; H, hydrogen; HSD, honestly significant difference; NaCl, sodium chloride; SEM, scanning electron micrograph; WT, wild-type.CC BY · PubMed Central
Fig 4 Exogenous delivery of WT vesicles restores the biofilm drug-resistant phenotype and matrix composition. (a) A diagram depicting the addition of purified WT EVs from C. albicans biofilm cultures to mutant biofilms. (b) Effect of exogenous WT biofilm EVs on biofilm fluconazole susceptibility for select ESCRT null mutants as measured by the 96-well XTT assay. Biofilm cultures of fluconazole-sensitive mutant strains amended with WT EVs (21,804 ± 1,711 EVs/ml) regain their ability to grow in the presence of fluconazole. Each experiment and assay was performed in triplicate. (c) Exogenous WT EVs rescue matrix production in ESCRT mutant biofilms. The fluconazole-susceptible biofilm of HSE1 null mutant does not produce extracellular matrix (upper SEM). The addition of exogenous vesicles restores the mutant’s ability to produce the extracellular matrix (lower SEM). Scale bars indicate 11 μm. (d) Exogenous EVs restore mannan and glucan concentrations in the biofilm matrix of HSE1 null mutant as measured by gas chromatography. Each experiment and assay was performed in triplicate. (e) Effect of exogenous biofilm EVs on drug susceptibility of select C. albicans matrix glucan-modification null mutants as measured by the 96-well XTT assay. The vesicle cargo mutants (PHR1, SUN41) regain their ability to grow in the presence of fluconazole after the addition of exogenous WT EVs. Each experiment and assay was performed in triplicate. Underlying data can be found in S1 Data. ESCRT, endosomal sorting complexes required for transport; EV, extracellular vesicle; SEM, scanning electron micrograph; SUN41, putative endo-beta-D-glucosidase; PHR1, putative glycanosyltransferase; WT, wild-type.
Fig 4 Exogenous delivery of WT vesicles restores the biofilm drug-resistant phenotype and matrix composition. (a) A diagram depicting the addition of purified WT EVs from C. albicans biofilm cultures to mutant biofilms. (b) Effect of exogenous WT biofilm EVs on biofilm fluconazole susceptibility for select ESCRT null mutants as measured by the 96-well XTT assay. Biofilm cultures of fluconazole-sensitive mutant strains amended with WT EVs (21,804 ± 1,711 EVs/ml) regain their ability to grow in the presence of fluconazole. Each experiment and assay was performed in triplicate. (c) Exogenous WT EVs rescue matrix production in ESCRT mutant biofilms. The fluconazole-susceptible biofilm of HSE1 null mutant does not produce extracellular matrix (upper SEM). The addition of exogenous vesicles restores the mutant’s ability to produce the extracellular matrix (lower SEM). Scale bars indicate 11 μm. (d) Exogenous EVs restore mannan and glucan concentrations in the biofilm matrix of HSE1 null mutant as measured by gas chromatography. Each experiment and assay was performed in triplicate. (e) Effect of exogenous biofilm EVs on drug susceptibility of select C. albicans matrix glucan-modification null mutants as measured by the 96-well XTT assay. The vesicle cargo mutants (PHR1, SUN41) regain their ability to grow in the presence of fluconazole after the addition of exogenous WT EVs. Each experiment and assay was performed in triplicate. Underlying data can be found in S1 Data. ESCRT, endosomal sorting complexes required for transport; EV, extracellular vesicle; SEM, scanning electron micrograph; SUN41, putative endo-beta-D-glucosidase; PHR1, putative glycanosyltransferase; WT, wild-type.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 260

Metadata

Authors
Zarnowski, R., Sanchez, H., Covelli, A. S., Dominguez, E., Jaromin, A., Bernhardt, J., Mitchell, K. F., Heiss, C., Azadi, P., Mitchell, A., & Andes, D. R.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Wrocław (PL)
  • Universität Greifswald (DE)
  • University of Georgia (US)
  • Carnegie Mellon University (US)
Corresponding author
Andes, David R.
Venue
PLOS Biology
Published
2018-10-08
Volume
16
Issue
10
Pages
e2006872
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W2894968361
Cited by
260
References
54
Citations by year
2026: 27 · 2025: 31 · 2024: 38 · 2023: 35 · 2022: 34 · 2021: 44 · 2020: 32 · 2019: 17 · 2018: 2
FWCI
17.93
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Funders
  • U.S. Department of Energy (DESC0015662)
  • National Institute of Allergy and Infectious Diseases (R01AI073289)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
Candida albicans, extracellular vesicles, biofilm, biofilm matrix, drug resistance, fluconazole, ESCRT, extracellular matrix polysaccharides, fungal pathogens, intercellular communication
MeSH terms
Extracellular Vesicles, Extracellular Polymeric Substance Matrix, Candida albicans, Fungal Proteins, Humans, Microscopy, Electron, Scanning, Models, Biological, Mutation, Biofilms, Cryoelectron Microscopy, Proteome, Drug Resistance, Fungal, Lipid Metabolism, Microbial Interactions, Endosomal Sorting Complexes Required for Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.